Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03110744
Title CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)
Acronym NCT-PMO-1601
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital Heidelberg
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Essen Essen 45147 Germany Details
National Center for Tumor Diseases Heidelberg 69120 Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field